WEDNESDAY, Feb. 20, 2019 (Pharmacist's Briefing) -- For first-line therapy of metastatic renal cell carcinoma, pembrolizumab plus axitinib and avelumab plus axitinib both show improved survival versus sunitinib, according to two studies published online Feb. 16 in the New England Journal of Medicine to coincide with the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Feb. 14 to 16 in San Francisco
WEDNESDAY, Feb. 20, 2019 (Pharmacist's Briefing) -- In sedentary overweight/obese older adults, morning exercise reduces systolic blood pressure, with additional benefit seen by combining exercise with regular breaks in sitting, according to a study published online Feb. 20 in Hypertension
What Your Patients Are Reading
THURSDAY, Feb. 21, 2019 (Pharmacist's Briefing) -- Infections with two strains of the sexually transmitted human papillomavirus (HPV) are showing marked declines among American women, and rising vaccination rates could be driving the trend
Hot Topics
WEDNESDAY, Feb. 20, 2019 (Pharmacist's Briefing) -- The U.S. Food and Drug Administration took steps Thursday to tighten regulation of over-the-counter sunscreen products
Industry News You Can Use
WEDNESDAY, Feb. 20, 2019 (Pharmacist's Briefing) -- The U.S. government may have to take steps to reduce vaccine exemptions for children if states do not do it, the head of the U.S. Food and Drug Administration suggested. His comments come as measles outbreaks rage in a number of states. Those outbreaks could have been prevented if children had all been vaccinated. But nearly all states allow children to attend school even if their parents opt out of inoculation programs, CNN reported